In last trading session, Artelo Biosciences, Inc. (NASDAQ:ARTL) saw 4,917,110 shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $1 trading at $0.04 or 3.79% at ring of the bell on the day assigns it a market valuation of $15.11 Million. That closing price of ARTL’s stock is at a discount of -342.3% from its 52-week high price of $4.423 and is indicating a premium of 54.9% from its 52-week low price of $0.451. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.63 Million shares which gives us an average trading volume of 2.65 Million if we extend that period to 3-months.
For Artelo Biosciences, Inc. (ARTL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 1 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.1 in the current quarter.
Artelo Biosciences, Inc. (NASDAQ:ARTL) trade information
Upright in the green during last session for gaining 3.79%, in the last five days ARTL remained trading in the green while hitting it’s week-highest on Friday, Jan 08 when the stock touched $1.24 price level, adding 19.35% to its value on the day. Artelo Biosciences, Inc.’s shares saw a change of 36.99% in year-to-date performance and have moved 12.89% in past 5-day. Artelo Biosciences, Inc. (NASDAQ:ARTL) showed a performance of 62.6% in past 30-days. Number of shares sold short was 688.38 Million shares which calculate 259.77 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $3 to the stock, which implies a rise of 200% to its current value. Analysts have been projecting $3 as a low price target for the stock while placing it at a high target of $3. It follows that stock’s current price would jump +200% in reaching the projected high whereas dropping to the targeted low would mean a loss of 200% for stock’s current value.
Artelo Biosciences, Inc. (ARTL) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0% during past 5 years. In 2021, company’s earnings growth rate is likely to be around -25.6% while estimates for its earnings growth in next 5 years are of 0%
Even if you’re not actively in crypto, you deserve to know what’s actually going on..
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets are already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.